Last reviewed · How we verify
NCT06633939: Okla Achokma
The Okla Achokma Project
NA trial testing Behavioral Treatment in Healthy in 280 participants. Completed in 31 August 2024.
6 August 2024
Quick facts
| Lead sponsor | University of Southern Mississippi |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 280 |
| Start date | 30 May 2024 |
| Primary completion | 6 August 2024 |
| Estimated completion | 31 August 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Behavioral Treatment — full drug profile →
Conditions studied
- Healthy — all drugs for Healthy →
- Diet — all drugs for Diet →
- Physical Activity — all drugs for Physical Activity →
Sponsor
University of Southern Mississippi
Who can join
18 and older, any sex, with Healthy or Diet. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Deep South Native Americans disparately suffer from diabetes, hypertension, and obesity with only 5-10% of Native Americans living past age 65 compared to 15-17% of Whites. Standard lifestyle interventions to improve diet and physical activity behaviors have shown improvement in weight and other cardiometabolic outcomes among Native Americans. The impact of lifestyle interventions on preventable chronic diseases among Native Americans is limited by the exclusion of a multi-level approach with cultural and social enhancements that address the spiritual and social domains of physical health. Therefore, there is an urgent need to determine how spiritual and social domains of health at individual and family levels may advance lifestyle management interventions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06633939
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Behavioral Treatment
Trials testing the same drug.
- NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
- NCT07032311 — Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk · NA · not yet recruiting
- NCT07018830 — Multicomponent Program for Addressing Cognition in Rural Communities · NA · completed
- NCT06467916 — The Development of PATH, a Program to Support NICU Parent Mental Health Through the Transition From Hospital to Home · NA · recruiting
- NCT07137117 — The Effect of Tele-Counseling Service on Nutrition, Exercise Attitude, and Medication Adherence After Bariatric Surgery · NA · recruiting
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other University of Southern Mississippi trials
Trials by the same sponsor.
- NCT05470296 — It's Native: Nudging Healthy Ways · NA · withdrawn
- NCT06529055 — Effects of Oral Nicotine and Caffeine Pouches on Anaerobic Performance, Autonomic Function, Cognition, and Behavior · NA · enrolling by invitation
- NCT05885672 — Improving the Early Detection of Cardiometabolic Disease Risk · enrolling by invitation
- NCT05997862 — A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity · Phase 1, PHASE2 · unknown
- NCT05651243 — Ketone Esters for Appetite, Cognition, and Cardiovascular Function in Individuals With Obesity and Insulin Resistance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06633939 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern Mississippi
- Last refreshed: 9 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06633939.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing